Search research articles
Contact Us
Filters
Showing results (91-100 of 300) with videos related to
Page
of 30
Sort By:
Leukemia & Lymphoma
|
October 28, 2023
Understanding treatment decisions for Hodgkin lymphoma: a qualitative study
Anita J Kumar, Laurie K Pearson, John B Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2022
ASCO Living Guidelines: The Next Frontier
Veda N Giri, Thomas K Oliver, R Bryan Rumble, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2005
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma
Jennifer R Brown, Heather Yeckes, Jonathan W Friedberg, et al.
Cancer
|
August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity
Jonathan W Friedberg, Donna Neuberg, Helen Kim, et al.
Annals of Internal Medicine
|
July 1, 2014
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study
Jane C Weeks, Hajime Uno, Nathan Taback, et al.
Molecular Cancer Therapeutics
|
June 5, 2019
Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells <i>In Vitro</i> and <i>In Vivo</i>
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma
Patrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736
Deborah M Stephens, Hongli Li, Michael L LeBlanc, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 31, 2016
Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse
Sughosh Dhakal, James E Bates, Carla Casulo, et al.
Page
of 30
Search research articles
Search
Showing results (91-100 of 300) with videos related to
Sort By:
Page
of 30
Leukemia & Lymphoma
|
October 28, 2023
Understanding treatment decisions for Hodgkin lymphoma: a qualitative study
Anita J Kumar, Laurie K Pearson, John B Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2022
ASCO Living Guidelines: The Next Frontier
Veda N Giri, Thomas K Oliver, R Bryan Rumble, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2005
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma
Jennifer R Brown, Heather Yeckes, Jonathan W Friedberg, et al.
Cancer
|
August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity
Jonathan W Friedberg, Donna Neuberg, Helen Kim, et al.
Annals of Internal Medicine
|
July 1, 2014
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study
Jane C Weeks, Hajime Uno, Nathan Taback, et al.
Molecular Cancer Therapeutics
|
June 5, 2019
Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells <i>In Vitro</i> and <i>In Vivo</i>
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma
Patrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736
Deborah M Stephens, Hongli Li, Michael L LeBlanc, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 31, 2016
Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse
Sughosh Dhakal, James E Bates, Carla Casulo, et al.
Page
of 30